EVALUATION OF ANTI-DIABETIC ACTIVTY OF DIFFERENT EXTRACTS OF MYRISTICA FRAGRANS HOUTT: IN VITRO AND IN SILICO STUDIES
Objective:Â This study is aimed to evaluate the anti-diabetic effect of sequentially extracted (hexane, dichloromethane, ethyl acetate, and ethanol) Myristica fragrans houttÂ (mace) through in vitroÂ and in silicoÂ studies.
Methods:Â The in vitroÂ anti-diabetic effect of the sequentially extracted plant were evaluated for its alpha-amylase inhibitory activity and the potential binding was studied by in silicoÂ studies using SchrÃ¶dinger Maestro.
Results:Â All extracts showed dose dependent alpha-amylase inhibitory effect. At concentration 500 Âµg/ml, all the extracts showed more than 60% inhibition of the alpha-amylase enzyme and the highest inhibition (81.30%) at 500Â Âµg/ml was observed in DCM extract of mace. Potential compounds were identified by in silicoÂ molecular docking studies of alpha-amylase with phytocomponents fromÂ DCM extract. Among the top threeÂ compoundsÂ from virtual screening, induced fit docking studies revealed 2,5-bis(3,4-dimethoxyphenyl)-3,4-dimethyloxolaneÂ possessed better binding affinity when compared with the drug metformin.
Conclusion:Â The obtained in vitroÂ and in silicoÂ results suggest that all extracts of Myristica fragrans can be used successfully for the management of diabetes mellitus.
Keywords: Myristica fragrans, Mace, Sequential extraction, Alpha-amylase, Molecular docking.
Rahimzadeh M, Jahanshahi S, Moein S, Moein MR. Evaluation of alpha-amylase inhibition by Urtica dioica and Juglans regia extracts. Iran J Basic Med Sci 2014;17(6):465-9.
Keerthana G, Kalaivani MK, Sumathy A. In-vitro alpha-amylase inhibitory and antioxidant activities of ethanolic leaf extract of Corton bonplandianum. Asian J Pharm Clin Res 2013;6(4):32-6.
Bhutkar MA, Bhise SB. In vitro assay of alpha amylase inhibitory activity of some indigenous plants. Int J Chem Sci 2012;10(1):457-62.
Perumal Samy R, Gopalakrishnakone P. Therapeutic potential of plants as anti-microbials for drug discovery. Evid Based Complement Alternat Med 2010;7(3):283-94.
Nagja T, Vimal K, Sanjeev A. Myristica fragrans: A comprehensive review. Int J Pharm Pharm Sci 2016;8(2):27-30.
Jeyaseelan EC, Jenothiny S, Pathmanathan MK, Jeyadevan JP. Antibacterial activity of sequentially extracted organic solvent extracts of fruits, flowers and leaves of Lawsonia inermis L. From Jaffna. Asian Pac J Trop Biomed 2012;2(10):798-802.
Sangeetha N, Rintu B. Optimization of culture parameters to enhance production of amylase and protease from Aspergillus awamori in a single fermentation. Afr J Bio Res 2010;4(3):73-80.
Kalpana S, Ramakrushna B, Anitha S. Evaluation of in vitro antioxidant and Î±-amylase inhibitory activity of Phyllanthus indofischeri bennet. Int J Pharm Pharm Sci 2016;8(11):131-6.
Farid R, Day T, Friesner RA, Pearlstein RA. New insights about HERG blockade obtained from protein modeling, potential energy mapping, and docking studies. Bioorg & Med Chem 2006;14:3160-73.
Maurus R, Begum A, Williams LK, Fredriksen JR, Zhang R, Withers SG, et al. Alternative catalytic anions differentially modulate human alpha-amylase activity and specificity. Biochemistry 2008;47(11):3332-44.
Kim S, Thiessen PA, Bolton EE, Chen J, Fu G, Gindulyte A, et al. PubChem substance and compound databases. Nucleic Acids Res 2016;44(D1):D1202-13.
Dey L, Attele AS, Yuan CS. Alternative therapies for Type 2 diabetes. Altern Med Rev 2002;7(1):45-58.
McDougall GJ, Shpiro F, Dobson P, Smith P, Blake A, Stewart D. Different polyphenolic components of soft fruits inhibit alpha-amylase and alpha-glucosidase. J Agric Food Chem 2005;53(7):2760-6.
Bhanudas NM. Evaluation of alpha amylase inhibitory potential of four traditional culinary leaves. Asian J Pharm Clin Res 2012;5(2):75-6.
Cragg GM, Newman DJ. Natural products: A continuing source of novel drug leads. Biochim Biophys Acta 2013;1830(6):3670-95.
Dharmendra KK, Archana RJ. Î±-glucosidase and Î±-amylase inhibitory activity of Indigofera cordifolia seeds and leaves extract. Int J Pharm Pharm Sci 2014;6(11):152-5.
How to Cite
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.